Ophthalmology · Stuart, FL
NPI
1083769939
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1050 SE Monterey Rd, Suite 104
Stuart, FL, 34994
Phone (772) 283-2020
Groups this clinician bills Medicare through
Medicare paid, 2024
$244K
4,455 services
Medicare patients, 2024
891
Average age 76
Drug cost, 2024
$1.6M
6,485 prescriptions
Company payments, 2025
$1,856
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rebecca G Bobo was code 99213 (office e&m - established), 680 times for 437 patients. In total Rebecca G Bobo billed 4,455 services in 26 codes, and Medicare paid $244K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-02-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 680 | 437 | $63.44 | $43K |
| 92083 Vision, Hearing, and Speech Services | Office | 673 | 552 | $44.20 | $30K |
| 92133 Computerized Ophthalmic Imaging | Office | 562 | 493 | $24.62 | $14K |
| 92014 Ophthalmological E&M | Office | 525 | 491 | $81.34 | $43K |
| 92250 Angiography | Office | 520 | 514 | $25.60 | $13K |
| 92020 Ophthalmological E&M | Office | 386 | 380 | $19.40 | $7,487 |
| 99214 Office E&M - Established | Office | 334 | 247 | $88.48 | $30K |
| 92134 Computerized Ophthalmic Imaging | Office | 232 | 218 | $27.98 | $6,490 |
| 76514 Ultrasound - Nonspecific | Office | 110 | 109 | $8.10 | $891 |
| 92004 Ophthalmological E&M | Office | 83 | 83 | $96.08 | $7,975 |
| 68761 Eye | Office | 70 | 32 | $86.20 | $6,034 |
| 99204 Office E&M - New | Office | 59 | 59 | $113.57 | $6,701 |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Office | 37 | 24 | $191.59 | $7,089 |
| 66761 Fluid Flow and Drainage of Eye (Any Method) | Office | 23 | 12 | $236.93 | $5,449 |
| 99203 Office E&M - New | Office | 17 | 17 | $80.72 | $1,372 |
By year: 2022 $257K for 4,281 services; 2023 $239K for 4,367 services; 2024 $244K for 4,455 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rebecca G Bobo prescribed most often to Medicare patients was Lumigan (Bimatoprost), with 1,521 prescriptions and refills. In total Rebecca G Bobo wrote 6,485 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lumigan Bimatoprost | 1,521 | 2,206 | 380 | $531K |
| Latanoprost Generic | 928 | 1,648 | 287 | $8,381 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 514 | 1,110 | 159 | $8,255 |
| Timolol Maleate Generic | 505 | 805 | 152 | $4,503 |
| Restasis Cyclosporine | 440 | 594 | 181 | $346K |
| Vyzulta Latanoprostene Bunod | 392 | 514 | 107 | $128K |
| Combigan Brimonidine Tartrate/Timolol | 315 | 436 | 64 | $82K |
| Brimonidine Tartrate Generic | 277 | 444 | 81 | $2,578 |
| Dorzolamide Hcl Generic | 221 | 443 | 63 | $3,296 |
| Rhopressa Netarsudil Mesylate | 220 | 322 | 65 | $86K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 168 | 230 | 52 | $74K |
| Alphagan P Brimonidine Tartrate | 143 | 206 | 42 | $39K |
| Prednisolone Acetate Generic | 106 | 150 | 68 | $4,631 |
| Xiidra Lifitegrast | 96 | 136 | 42 | $84K |
| Cequa Cyclosporine | 66 | 75 | 22 | $42K |
Brand drugs: 3,989 claims; generic drugs: 2,496 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rebecca G Bobo $1,856 ($1,856 in general payments such as food, travel and fees) from 14 companies. The largest payer was Tarsus Pharmaceuticals, Inc. with $338.
| Company | Payments | Amount |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS | 9 | $338 |
| Abbvie Inc. ABBV | 19 | $316 |
| Bausch & Lomb Americas Inc. BLCO | 3 | $304 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 15 | $296 |
| Harrow Eye, LLC | 6 | $153 |
| Mallinckrodt Hospital Products Inc. | 3 | $81.78 |
| ANI Pharmaceuticals, Inc. ANIP | 3 | $73.61 |
| Oyster Point Pharma, Inc. | 4 | $71.05 |
| Alcon Vision LLC ALC | 2 | $52.44 |
| Apellis Pharmaceuticals, Inc. APLS | 2 | $46.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.